| $376M | ||
| $350M | ||
| $215M | ||
| $107M | ||
| $100M | ||
| $99M |
Buys | $102,150 | 1 | 100 |
Sells | $0 | 0 | 0 |
| GRAVES JEFFREY A | director | 1 | $102,150 | 0 | $0 | $102,150 |
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
Over the last 12 months, insiders at Integra LifeSciences Holdings Corporation have bought $102,150 and sold $0 worth of Integra LifeSciences Holdings Corporation stock.
On average, over the past 5 years, insiders at Integra LifeSciences Holdings Corporation have bought $999,322 and sold $12.62M worth of stock each year.
Highest buying activity among insiders over the last 12 months: GRAVES JEFFREY A (director) — $102,150.
The last purchase of 9,000 shares for transaction amount of $102,150 was made by GRAVES JEFFREY A (director) on 2025‑11‑05.
| 2025-11-05 | GRAVES JEFFREY A | director | 9,000 0.0109% | $11.35 | $102,150 | +5.35% | ||
| 2024-12-03 | Sale | Schwartz Eric | EVP, Chief Legal Officer & Sec | 4,070 0.0053% | $24.59 | $100,102 | -39.71% | |
| 2024-12-02 | Sale | McBreen Michael J. | EVP & President, CSS | 1,700 0.0022% | $24.16 | $41,064 | -39.52% | |
| 2024-08-19 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 1,191 0.0015% | $21.58 | $25,701 | -10.58% | |
| 2024-05-23 | ESSIG STUART | Exec. Chairman of the Board | 52,641 0.0668% | $28.49 | $1.5M | -21.66% | ||
| 2024-05-21 | HILL BARBARA B | director | 36,350 0.0462% | $27.40 | $995,816 | -18.24% | ||
| 2024-03-06 | Sale | DAVIS ROBERT T. JR. | EVP & President, TT | 8,348 0.0109% | $36.59 | $305,492 | -31.89% | |
| 2023-08-09 | Sale | Mosebrook Jeffrey | SVP, Fin & PAO | 1,177 0.0014% | $44.46 | $52,329 | -14.98% | |
| 2023-06-01 | Schwartz Eric | EVP, Chief Legal Officer & Sec | 2,640 0.0032% | $37.89 | $100,035 | +2.94% | ||
| 2023-06-01 | De Witte Jan | President & CEO | 7,792 0.0095% | $38.50 | $299,986 | +2.94% | ||
| 2023-03-07 | Sale | McBreen Michael J. | EVP & President, CSS | 1,843 0.0023% | $54.29 | $100,064 | -22.82% | |
| 2023-03-01 | Sale | DAVIS ROBERT T. JR. | EVP & President, TT | 1,566 0.0019% | $55.21 | $86,463 | -23.10% | |
| 2023-02-27 | Sale | Evoli Lisa | EVP & CHRO | 3,767 0.0046% | $57.00 | $214,731 | -25.87% | |
| 2022-12-08 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 279 0.0003% | $56.22 | $15,684 | -21.17% | |
| 2022-08-10 | Sale | Evoli Lisa | Executive Vice President &CHRO | 1,165 0.0014% | $55.81 | $65,020 | -7.17% | |
| 2022-08-05 | Sale | Murphy Raymond G. | 8,000 0.0096% | $55.78 | $446,266 | -5.84% | ||
| 2022-08-02 | Sale | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 437 0.0005% | $56.77 | $24,811 | -5.40% | |
| 2022-06-15 | Sale | Evoli Lisa | Executive Vice President &CHRO | 900 0.0011% | $55.93 | $50,337 | -3.92% | |
| 2022-05-24 | Sale | Evoli Lisa | Executive Vice President &CHRO | 250 0.0003% | $59.85 | $14,963 | -8.85% | |
| 2022-04-04 | Sale | Coleman Glenn | Executive Vice President & COO | 6,268 0.0077% | $66.04 | $413,939 | -14.16% |
| GRAVES JEFFREY A | director | 41086 0.0528% | $719,415.86 | 1 | 0 | |
| CARUSO RICHARD E | 10 percent owner | 10291205 13.2283% | $180.2M | 1 | 12 | +23.04% |
| Tru St Partnership, L.P. | 10 percent owner | 8515930 10.9464% | $149.11M | 0 | 9 | |
| SOROS GEORGE | 10 percent owner | 2725300 3.5031% | $47.72M | 0 | 17 | |
| ESSIG STUART | Exec. Chairman of the Board | 487922 0.6272% | $8.54M | 1 | 74 | <0.0001% |
| Arduini Peter J | President & CEO | 216713 0.2786% | $3.79M | 0 | 14 | |
| SULLIVAN JAMES M | director | 59604 0.0766% | $1.04M | 0 | 8 | |
| Schwartz Eric | EVP, Chief Legal Officer & Sec | 59511 0.0765% | $1.04M | 1 | 4 | +2.94% |
| McBreen Michael J. | EVP & President, CSS | 56182 0.0722% | $983,746.82 | 0 | 6 | |
| DAVIS ROBERT T. JR. | EVP & President, TT | 49893 0.0641% | $873,626.43 | 0 | 5 | |
| REUVERS DANIEL L. | CVP,PRES - CODMAN SPC SURGICAL | 42473 0.0546% | $743,702.23 | 0 | 7 | |
| Coleman Glenn | Executive Vice President & COO | 41288 0.0531% | $722,952.88 | 0 | 16 | |
| Murphy Raymond G. | 40825 0.0525% | $714,845.75 | 0 | 7 | ||
| MOREL DONALD E JR | director | 37112 0.0477% | $649,831.12 | 2 | 0 | +6.47% |
| BRADLEY KEITH | director | 37065 0.0476% | $649,008.15 | 0 | 8 | |
| HILL BARBARA B | director | 36350 0.0467% | $636,488.50 | 4 | 0 | +3.52% |
| Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | 36088 0.0464% | $631,900.88 | 0 | 10 | |
| HENNEMAN JOHN B III | CorpVP, CAO | 34159 0.0439% | $598,124.09 | 0 | 54 | |
| PALTRIDGE ROBERT D | Corp VP, Pres. Extrem Recon | 33590 0.0432% | $588,160.90 | 0 | 4 | |
| SCHADE CHRISTIAN S | director | 32633 0.0419% | $571,403.83 | 0 | 4 | |
| GORELICK RICHARD D. | Corp VP, Gen Counsel & Sec | 21565 0.0277% | $377,603.15 | 0 | 6 | |
| NOCIOLO DON R | Senior VP, Operations | 18984 0.0244% | $332,409.84 | 0 | 7 | |
| Evoli Lisa | EVP & CHRO | 18605 0.0239% | $325,773.55 | 0 | 12 | |
| MOORADIAN JOHN | Corp VP, Global Ops & Supp Chn | 15410 0.0198% | $269,829.10 | 0 | 5 | |
| De Witte Jan | President & CEO | 12798 0.0165% | $224,092.98 | 1 | 0 | +2.94% |
| Burhop Kenneth | CORPVP,CHIEFSCIENTIFIC OFFICER | 12465 0.016% | $218,262.15 | 0 | 1 | |
| HOLTZ DAVID B | Senior VP, Finance (1) | 10248 0.0132% | $179,442.48 | 0 | 6 | |
| LEONETTI DEBORAH A | Corp VP, Glbl Servs & Repair | 8715 0.0112% | $152,599.65 | 0 | 11 | |
| Corbin Jerry E | Corp VP & Corporate Controller | 8677 0.0112% | $151,934.27 | 0 | 4 | |
| VINHAIS JOSEPH | Corp VP,Quality&Transformation | 8231 0.0106% | $144,124.81 | 0 | 4 | |
| CARLOZZI GERARD S | Executive Vice President & COO | 7813 0.01% | $136,805.63 | 0 | 21 | |
| OGRADY JUDITH | CorpVP,Reg.Affairs,CorpCompli | 7206 0.0093% | $126,177.06 | 0 | 41 | |
| LARKIN BRIAN | Corp VP, Pres.Gbl Spine &Ortho | 7069 0.0091% | $123,778.19 | 0 | 4 | |
| Ballintyn Rhonda Germany | director | 3665 0.0047% | $64,174.15 | 1 | 0 | +3.09% |
| MOSZKOWSKI NEAL | director | 3511 0.0045% | $61,477.61 | 0 | 2 | |
| VANLENT ANNE | director | 3478 0.0045% | $60,899.78 | 0 | 1 | |
| PIERSHBACHER MICHAEL | Senior V.P.., R&D | 0 0% | $0 | 0 | 4 |
| Increased Positions | 108 | +45.19% | 8M | +10.73% |
| Decreased Positions | 106 | -44.35% | 5M | -6.68% |
| New Positions | 36 | New | 3M | New |
| Sold Out Positions | 33 | Sold Out | 2M | Sold Out |
| Total Postitions | 241 | +0.84% | 76M | +4.06% |
| Blackrock, Inc. | $122,852.00 | 13.11% | 10.23M | -122,569 | -1.18% | 2025-09-30 |
| Rubric Capital Management Lp | $91,924.00 | 9.81% | 7.65M | +300,000 | +4.08% | 2025-09-30 |
| Vanguard Group Inc | $88,623.00 | 9.46% | 7.38M | -199,166 | -2.63% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $47,012.00 | 5.02% | 3.91M | +21,906 | +0.56% | 2025-09-30 |
| Morgan Stanley | $45,934.00 | 4.9% | 3.82M | -109,347 | -2.78% | 2025-09-30 |
| Invesco Ltd. | $41,926.00 | 4.48% | 3.49M | -46,299 | -1.31% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $38,249.00 | 4.08% | 3.18M | +267,134 | +9.16% | 2025-09-30 |
| State Street Corp | $33,519.00 | 3.58% | 2.79M | -35,567 | -1.26% | 2025-09-30 |
| Paradigm Capital Management Inc/Ny | $30,383.00 | 3.24% | 2.53M | +348,300 | +15.97% | 2025-09-30 |
| Geode Capital Management, Llc | $18,594.00 | 1.99% | 1.55M | -94,331 | -5.74% | 2025-09-30 |